Lange T, Sprague JL, Vij R, Alonso-Roman R, Jablonowski N, Radosa S, Krüger T, Kniemeyer O, Hillmann F, Brakhage AA, Allert S, Brunke S, Hube B (2025) "Pour some sugar on me"-Environmental Candida albicans isolates and the evolution of increased pathogenicity and antifungal resistance through sugar adaptation. PLoS Pathog 21(10), e1013542.

Alonso-Roman R, Mosig AS, Figge MT, Papenfort K, Eggeling C, Schacher FH, Hube B^#, Gresnigt MS (2024) Organ-on-chip models for infectious disease research. Nat Microbiol 9(4), 891-904. (Review)

Kaden T, Alonso-Román R, Stallhofer J, Gresnigt MS, Hube B, Mosig AS (2024) Leveraging organ-on-chip models to investigate host-microbiota dynamics and targeted therapies for inflammatory bowel disease. Adv Healthc Mater 14(10), e2402756. (Review)

Kaden T^*, Alonso-Roman R^*, Akbarimoghaddam P^*, Mosig AS, Graf K, Raasch M, Hoffmann B, Figge MT^#, Hube B^#, Gresnigt MS^# (2024) Modeling of intravenous caspofungin administration using an intestine-on-chip reveals altered Candida albicans microcolonies and pathogenicity. Biomaterials 307, 122525.

Alonso-Roman R, Last A, Mirhakkak MH, Sprague JL, Möller L, Großmann P, Graf K, Gratz R, Mogavero S, Vylkova S, Panagiotou G, Schäuble S, Hube B, Gresnigt MS (2022) Lactobacillus rhamnosus colonisation antagonizes Candida albicans by forcing metabolic adaptations that compromise pathogenicity. Nat Commun 13(1), 3192.

García-Díaz M, Cendra MDM, Alonso-Roman R, Urdániz M, Torrents E, Martínez E (2022) Mimicking the intestinal host-pathogen interactions in a 3D in vitro model: The role of the Mucus layer. Pharmaceutics 14(8), 1552.